HVA is proud that our CEO, Matt Hickey contributed to the Lung Cancer Policy Network’s new policy brief, Timeliness matters: improving lung cancer care with timed targets.
The brief is an important read for policymakers, healthcare leaders, commissioners, providers and organisations focused on cancer pathway performance. It explores how timed targets can support clearer accountability in lung cancer diagnosis, treatment and care, while also highlighting the need to address resource gaps, system bottlenecks and performance over time.
Timed targets matter. They can create focus, expose delay and help systems understand whether patients are moving through care quickly enough.
But targets alone are not enough.
If interpreted in isolation, targets can also create unintended incentives. The risk is that organisations focus on meeting the measure rather than improving the pathway — moving patients through a system without enough visibility of outcomes, continuity, appropriateness of care or downstream impact.
That is why context matters.
Through QALYfAI® — Healthcare Performance Intelligence, HVA turns fragmented healthcare data into performance intelligence for organisations that fund, administer, procure, provide and indemnify healthcare.
This helps identify which providers, pathways and healthcare solutions deliver value beyond cost, where leakage and variation sit, where networks can improve, and where future commercial, legal, regulatory and reputational exposure may be forming.
In lung cancer, as across many complex healthcare pathways, the challenge is not only to set targets. It is to understand whether those targets are driving better care.
Read the Lung Cancer Policy Network brief here: https://www.lungcancerpolicynetwork.com/app/uploads/Timeliness-matters-improving-lung-cancer-care-wth-timed-targets.pdf
